Introduction
IL-12 is a heterodimeric cytokine with multiple immunoregulatory activities (1, 2) . A critical component of the host's innate immune response to infection, IL-12 is produced early during the inflammatory response by macrophages. It enhances natural killer (NK) 1 cell cytoxicity severalfold and rapidly induces the production of IFN ␥ , the latter enhancing the antimicrobial activity of phagocytic cells (3) (4) (5) (6) . IL-12 is also a crucial participant in the development of acquired immune responses. It induces the differentiation of Th1 cells through its ability to prime naive Th0 cells for high IFN ␥ production (7, 8) . Furthermore, it is a potent growth factor for CD8 ϩ T cells (7) and enhances cytolytic responses to alloantigens (9) (10) (11) and in anti-CD3 redirected assays (12) .
Here, we have evaluated the role of IL-12 in generating cytolytic T lymphocyte (CTL) responses to influenza virus, which continues to be a source of significant morbidity and mortality in humans. We have previously shown that potent human CD8 ϩ CTL responses to live or nonreplicating heatinactivated influenza virus can be generated from freshly isolated blood T cells, provided dendritic cells are the antigenpresenting cells (APCs) (13, 14) . The response is independent of CD4 ϩ T cells or exogenous cytokines. Small numbers of dendritic cells suffice, whereas other APCs (macrophages, B cells) are inactive in this regard. Dendritic cells effect the development of Th1 cells from Th0 cells by the production of IL-12 (15) , suggesting that IL-12 is a key component by which these APCs induce T cell-mediated immune responses. Using the influenza virus system as a model, we show that dendritic cells induce potent CTL responses without producing significant levels of IL-12 endogenously. However, the exogenous application of IL-12 significantly enhances these responses, especially when the baseline CTL response of the donor is poor, or if the number of dendritic cells is limiting. Based on these findings we suggest that IL-12 may be a useful adjuvant for the induction of CTL responses, especially when delivered concomitantly with dendritic cells.
Methods

Culture medium
RPMI-1640 (Gibco Laboratories, Grand Island, NY) supplemented with 20 ug/ml gentamicin, 5% human serum, and 10 mM Hepes buffer.
Blood mononuclear cells
T cells. PBMCs were isolated from buffy coats by density gradient centrifugation over Ficoll Hypaque. T cell-enriched and T cell-depleted (ER-) fractions were prepared by sheep erythrocyte rosetting. T cells were further purified by removal of monocytes, NK cells, and MHC class II ϩ cells by panning with antibodies to CD11b, CD16, and DR, as described (13) . T cell subsets (CD4 ϩ and CD8 ϩ ) were negatively selected by incubation with Leu 2 or Leu 3 mAbs, followed by panning onto plastic plates coated with goat anti-mouse IgG (13) .
Antigen presenting cells. Monocytes were obtained from ERcells by adherence to plastic for 90 min. The monocytes were dislodged and used as targets in 51 Cr release assays (see below). Nonadherent ER-cells were depleted of residual monocytes by panning on gamma globulin-coated dishes. The remaining cells (primarily B cells and dendritic cells) were adequately enriched for dendritic cells to induce strong CTL responses (13) . Since B cells pulsed with influenza virus do not elicit CTL responses, in part because the B cell is not infected with influenza virus (13), we used mixtures of B cells and dendritic cells as APCs in some experiments. Highly purified dendritic cells ( Ͼ 75%) were obtained as low density cells by metrizamide gradient centrifugation, as previously described (13) . tains hemolytic and hemagglutinating activity, is as potent as live virus in inducing CD8 ϩ antiinfluenza CTL responses (14) . 
Cytokines
Neutralizing antibodies
Polyclonal goat anti-human IL-12, IL-2R (alpha chain, CD25), and IFN ␥ antibodies were purchased from R & D Systems, Inc. The hybridoma producing neutralizing anti-human IL-12 monoclonal antibody (C8.6) was kindly provided by Dr. G. Trinchieri of the Wistar Institute (Philadelphia, PA).
Induction of CTL responses
Dendritic cells were infected with 1,000 HAU/ml (moi of 2-4) of different forms of live or heat-inactivated influenza virus for 1 h at 37 Њ C in serum free medium, washed extensively, and added to bulk cultures of purified syngeneic T cells in 24-well or 48-well plastic dishes (Falcon Labware, Lincoln Park, NJ). After 7 d, the cells were harvested and distributed in varying numbers in 100-l vol to 96-well microtiter plates. CTL activity was measured using a standard 51 Cr-release assay with infected or uninfected macrophages, as previously described (13) . Effector:target (E:T) ratios were 30:1-40:1. In brief, macrophages were brought to 10 7 /ml in serum-free medium, and infected with 1,000 HAU/ml of influenza virus. The cells were simultaneously labeled with 51 Cr by the addition of 400 Ci of Na
51
CrO 4 (1 mCi/ml, sterile stock; New England Nuclear, Boston, MA) per milliliter. The targets were then washed four times, resuspended to 2 ϫ 10 5 / ml, and aliquoted in 50 l vol to 96-well round bottom dishes containing effector cells. Percent specific 51 Cr release was calculated from the following formula: 100 ϫ ([release by CTL Ϫ spontaneous release]/ [total release Ϫ spontaneous release]). Spontaneous release was generally 15% of the total release.
Proliferation assays
2 ϫ 10 5 bulk or CD8 ϩ T cells were plated in 96-well flat bottomed plates (Costar, Cambridge, MA) in the presence or absence of varying concentrations of cytokines. APCs were partially purified dendritic cells (T:APC ratio of 5:1) or purified dendritic cells (T:APC ratio of 30:1). APCs were infected with influenza virus as described above. Uninfected APCs served as controls. Proliferation was determined on days 5-6 with the addition of 4 Ci/ml of
Results
IL-12
is not produced in dendritic cell-dependent CTL responses. Potent antiinfluenza CTL responses are induced from resting CD8 ϩ T cells when dendritic cells are the APCs (13) . Dendritic cells can produce IL-12 (15, 16) and direct the development of Th1 cells from CD4 ϩ T cells (15) . However, it is not known whether IL-12 is synthesized after infection with virus and during contact with CD8 ϩ T cells. Using a sensitive ELISA system, we found that dendritic cells infected with live replicating influenza virus produced little to no IL-12 p70 heterodimer (range of 4-10 pg/ml in four separate experiments). Furthermore, significant levels of IL-12 were not detectable in T cell-dendritic cell culture supernatants over the 7-d period during which CD8 ϩ CTLs normally develop ( Ͻ 15 pg/ml). In contrast the cytokines IL-2, TNF ␣ , IFN ␥ and IL-6 were detectable by ELISA (data not shown). Several other stimuli including LPS (reported to induce IL-12 mRNA in murine splenic dendritic cells, [17] ), superantigens (staphylococcal enterotoxins), or addition of allogeneic T cells also failed to elicit high levels of IL-12 by dendritic cells.
In the CTL cultures, dendritic cells were added at 1 cell per 30 T cells. We considered the possibility that very low levels of IL-12 were produced in the supernatants. Neutralizing anti-IL-12 antibody was therefore added to the culture system. CTL responses were not blocked by anti-IL-12 antibody (5-25 g/ml [ Fig. 1 ] and data not shown) but were significantly suppressed by the addition of anti-IL-2 R antibody ( ␣ chain specific). IFN ␥ production was also unaffected by the addition of anti-IL-12 to the dendritic cell-T cell cultures. This suggests that endogenous IL-2, rather than IL-12, was responsible for IFN ␥ production. Indeed, IFN ␥ levels were markedly diminished by the addition of anti-IL-2 R ␣ antibody (Fig. 1 ). Thus our data suggest that dendritic cells do not produce biologically significant levels of IL-12 after virus infection, and that IL-12 is not produced during the development of potent antiviral CTLs. The antiinfluenza CTLs that are generated in bulk T cell cultures by virus-infected dendritic cells are CD8 ϩ (13). However, there is a substantial number of CD4 ϩ T cells presumably responding to influenza antigens in a class II restricted fashion. Even their presence, however, was insufficient to elicit IL-12 from influenza infected dendritic cells.
IL-12 enhances T cell proliferative responses to influenzavirus infected dendritic cells. IL-12 stimulates the proliferation of activated T and NK cells but causes minimal proliferation of resting peripheral blood mononuclear cells (7)
. We evaluated the effects of IL-12 on enhancing T cell proliferative responses to influenza virus-infected dendritic cells. Marked increases in proliferative responses were noted with the addition of IL-12 at low doses (Fig. 2 ). IL-12 is known to enhance proliferative responses to mitogen-activated T cells in the picomolar range (7). This was true for both bulk T cells (Fig. 2 A ) , as well as for highly purifed CD8 ϩ T cells (Fig. 2 B ) . Background responses were minimal. T cell yields were increased up to twofold (data not shown). We also evaluated IL-15, a cytokine which shares many of the properties of IL-2 (18) , and enhances CD4 ϩ T cell-dependent responses to antigen (19) . In contrast to IL-12, IL-15 produced dramatic background responses in bulk T cell populations (Fig. 2 C ) . Antigen specific T cell proliferative responses were still evident, however. IL-15 can induce some proliferation in bulk populations of human blood mononuclear cells (19) . When IL-15 was added to purified CD8 ϩ T cells, the responses generated to uninfected vs virus-infected dendritic cells was similar even with low doses, e.g., 50 pg/ml (data not shown).
IL-12 enhances weak antiviral cytolytic T cell responses. While dendritic cells induce strong CD8 ϩ CTL responses to influenza virus, macrophages are weak or inactive. This may be due to apoptosis, observed 12-16 h after infection of macrophages with virus (20). However, macrophages are useful as target cells in short term CTL assays because Ͼ 70% get infected. B cells are poor stimulators of the T cell response to the virus, probably because they are infected poorly with influenza (13) . As a result it is convenient for eliciting CTL responses to select macrophages as CTL targets, and to use T and macrophage-depleted blood populations as partially enriched sources of dendritic cells. The latter generally contain about 3-5% dendritic cells and are highly effective at inducing CD8 ϩ CTL responses (13) .
IL-12 (100 pg/ml) enhanced the cytolytic activity of bulk T cells towards influenza-infected, macrophage target cells (Fig.  3) . Two situations were identified where IL-12 was most effective. When low doses of APCs were used (T:APC ratio ϭ 30:1, Fig. 3A or T:dendritic cell ratio ϭ 100:1, Fig. 3 B ) , IL-12 restored cytolytic activity to levels seen at higher doses of APCs. IL-12 was also effective when the blood donors had weak baseline antiinfluenza CTL responses (Fig. 3 B ) . The enhancing effects of IL-12 were also evident with highly purified CD8 ϩ T cells that were stimulated with influenza-infected dendritic cells (Fig. 4) . We confirmed that the responding cells in the preparation were primarily CD8 ϩ , by staining with monoclonal antibodies at the end of the 7-d culture period (data not shown). , were uninfected or infected with influenza virus and added at various ratios to bulk T cells. IL-12 was added at 100 pg/ml. Lytic activity was determined after 7 d on syngeneic macrophage-infected targets (E:T ratio ϭ 40:1). Lysis of uninfected targets was Ͻ 5% (data not shown).
In summary, IL-12 appears to be most effective in enhancing CD8 ϩ CTL responses when APC numbers are limiting or the CTL response of the donor is weak to begin with.
IFN ␥ is not responsible for the IL-12-induced enhancement of CTL responses. IL-12 has a major role in facilitating the production of IFN ␥ by peripheral blood lymphocytes (reviewed in [1] ). IL-12 enhanced both antiviral cytolytic responses and IFN ␥ production in a dose-dependent manner (Fig. 5 A ) . The highest responses were observed at doses of 100-300 pg/ml, similar to that seen in the T cell proliferation assays (Fig. 2) . Similar results were obtained when ( a ) CD8 ϩ T cells were used (data not shown), or ( b ) heat inactivated, After 7 d, effector cells were harvested and lytic activity was determined on syngeneic macrophage-infected targets at various E:T ratios. Lysis of uninfected targets was Ͻ 5% at all E:T ratios used (data not shown). This result is typical of experiments with donors exhibiting CD8ϩ CTL responses of 20-30% without IL-12.
replication deficient virus was used (Fig. 5 B) . Even at low doses (10 pg/ml), there was greater than fivefold increase in the quantity of IFN␥ produced. This sensitivity to IL-12 has been described in other culture systems (1, 5, 6) .
We considered the possibility that IFN␥ production induced by IL-12 was mediating the induction of CD8ϩ CTLs by virus-infected dendritic cells. Endogenous IL-12 production is critical to the generation of NK cell and T cell responses through the production of IFN␥, best demonstrated in models of bacterial and parasitic infections (reviewed in [1] ). We added large doses of neutralizing anti-IFN␥ antibody to cocultures of T cells and virus-infected dendritic cells in the presence of IL-12. As seen in Table I , the antibody did not block the induction of cytolytic activity in highly purified CD8ϩ T cell populations. We confirmed that significant amounts of IFN␥ were being synthesized in the culture medium in response to IL-12 (up to 2.7 ng/ml). Since our cultures were extensively depleted of NK cells, it is unlikely that they were the source of IFN␥ production (see below). We verified that the major responding cells in the cultures after 7 d were CD8ϩ T cells and not NK cells by FACS ® analysis. We determined that IL-12 was responsible for the majority of IFN␥ production by CD8ϩ CTLs. Anti-IL-12 neutralizing antibody blocked the induction of IFN␥ release induced by IL-12, as well as the enhanced CTL responses. Anti-IL-2 R ␣ only partially reduced the IFN␥ release and CTL responses induced by IL-12 (by ‫ف‬ 40%, data not shown), indicating that the majority of IFN␥ produced is due to IL-12.
Comparison of a panel of cytokines on the enhancement of antiviral CTL responses. IL-12 was compared with a panel of cytokines that are also known to promote CD8ϩ CTL responses. IL-12 was the most potent enhancer of antigendependent CTLs (Fig. 6, A and B) . IL-7, a growth factor implicated in the development of CD8ϩ CTLs (21), appeared to be considerably less effective even when added at 1 ng/ml. Interestingly, IL-4, a key cytokine for the induction of Th2 responses, and which normally counteracts the effects of IL-12, also enhanced the CTL responses significantly. IL-15 increased the CTL response as well, but also caused a substantial rise in the background (Fig. 6, hatched bars) , as noted previously in the T cell proliferation assays (Fig. 2) . IL-2 was similar to IL-15 in inducing backgrounds and combinations of IL-2 and IL-12 were not synergistic in enhancing CTL responses (data not shown).
Discussion
Activation of antiviral CD8ϩ CTLs by dendritic cells is enhanced by IL-12.
Dendritic cells are specialized antigen-presenting cells for the induction of T cell-mediated immune responses (reviewed in [22] ). Their efficacy is based on their ability to prime CD4ϩ and CD8ϩ T cells in small numbers and high ex- pression of adhesins, costimulators, and intracellular vesicles critical for antigen presentation. Another means by which dendritic cells induce potent T cell responses is via the release of IL-12.
Using murine TCR transgenic CD4ϩ T cells, Macatonia et al. (15) showed that dendritic cells induce the differentiation of naive T cells into IFN␥ producing Th1 cells by synthesizing IL-12.
Dendritic cells induce potent human antiviral CD8ϩ CTL responses without the requirement for CD4ϩ T cells or exogenous cytokines (13) . We hypothesized, therefore, that dendritic cells produce IL-12 when stimulating strong antiviral CD8ϩ CTL responses. However, dendritic cells did not produce significant levels of IL-12 after influenza virus infection or when stimulating either bulk or purified CD8ϩ T cells. Several stimuli known to produce IL-12 from human macrophages, e.g., LPS, Staphylococcal aureus Cowan strain 1, allogeneic T cells, in our hands induced little to no IL-12 when added to human blood dendritic cells. IL-12 may only be mobilized by dendritic cells after certain conditions of T cell activation (15) . For example, interaction between CD40L on activated T cells and CD40 on APCs is critical for the priming of Th1 cells (23, 24) . The CD8ϩ CTLs generated in our system may express only low levels of CD40L. Alternatively, the production of IL-12 may critically depend on the source and/or the maturational state of dendritic cells.
The addition of low doses of IL-12 to purified bulk or CD8ϩ T cells and influenza virus-infected dendritic cells increased both the proliferative and CTL activities substantially (2-20-fold). Our study provides the first evidence of the enhancing effects of IL-12 on human antiviral CD8ϩ T cell responses. In those instances where donors had weak or poor baseline antiviral responses, the effect of adding IL-12 was dramatic. A strong antiviral immune response was elicited where little to none could be previously detected (Figs. 3 and  6 ). We feel this is an amplification of a low level of CD8ϩ T cell memory rather than a primary response, since one would not expect to detect levels of 30-40% CTL lysis in a primary response. While enhancement to such levels are seen with IL-12 in CTL responses to alloantigens or after stimulation with anti-CD3, there the number of responsive T cells is very high (9, 10, 12, 25) . IL-12 was also effective when the dose of dendritic cells was less than optimal or limiting (Fig. 3) .
IL-12 directly amplifies the antiviral effects of highly purified CD8ϩ T cells. The amplification of both the proliferative and the antiviral CTL responses correlated with the amount of IFN␥ produced in the cultures. In these respects, IL-12 effects on enhancing antiviral CTLs is like the effects on bulk NK cells (5, 6) , as long as antigen is being presented by dendritic cells.
Mechanism of IL-12 in enhancing CTL responses. IL-12 likely increases CTL responses through several ways. By functioning as a growth factor (7), it increases the number of T cells responding to antigen (up to twofold as shown here and reported in reference 12), and enhances the production of IL-2 (19, 26) and/or the expression of the IL-2 high affinity receptor (CD25, [27] ). The effect of IL-12 may be direct since it is not blocked by anti-IL-2R␣ (7, (10) (11) (12) . Activation of NK cells by IL-12 is similarly not dependent on cytokines such as IL-2 (1, 5, 6) . In our system IL-2 was critical, since the addition of anti-IL-2R␣ antibody substantially blocked CTL responses as described by others (9) .
IL-12 may also upregulate the expression of perforin (11), serine esterase levels and cytotoxic granules in CD8ϩ CTLs (10, 12) . A direct increase in the the CTL precursor frequency has also been postulated. However, we were unable to measure enhanced CTLp levels under limiting dilution conditions (data not shown).
IL-12-induced IFN␥ could directly enhance antiviral responses through its effects on infected target cells. This is one mechanism by which NK cells clear virus (28) . We found, however, that the addition of neutralizing anti-IFN␥ antibodies did not block either the induction of or killing capacity of CD8ϩ CTLs in the presence of IL-12. These findings are in concordance with those of Mehrortra et al. (12) who showed that the synergistic effects of IL-2 and IL-12 on CTL generation were not blocked by anti-IFN␥, and Bloom et al. (11) in the murine system where allospecific CTL generation was studied.
Our results do not rule out a role for IFN␥ in antiinfluenza responses, however, or of cytokines such as TNF␣ which are also produced in response to IL-12. This is because our assays are designed to measure cytolytic activity of virus-infected target cells vs elimination of virus through other inhibitory mechanisms. IFN␥ can clear infection by affecting viral RNA synthesis and stability, replication, and induction of mediators such as nitric oxide (29) . Such mechanisms, rather than direct cytolytic activity, are thought to be the primary means by which hepatitis virus and other cytopathic infections are cleared (30) .
When compared to other T cell growth factors, IL-12 appeared to be the most efficient at enhancing CTL responses. IL-2 and IL-15, while partly effective, gave high background responses possibly because of effects on IL-2 R␤ expressing T cells. IL-15 was tested because it can amplify dendritic celldependent T cell responses (31) and increases antigen-specific proliferative T cell responses (19) . IL-12 and IL-15 are synergistic in augmenting NK cell CTL function and IFN␥ production (18), but were not evaluated together because of the observed background activity of IL-15. Besides inducing the development of Th2 cells from naive CD4ϩ T cells, IL-4 can augment CTL responses including antiinfluenza CTL responses (32), as shown here (Fig. 6) . The pathway by which IL-4 enhances dendritic cell-dependent CTL responses is not known. However, IL-4 is known to prime PBMC for IL-12 production in response to LPS or S. aureus (33) . It is possible that the effects of IL-4 seen here are mediated through dendritic cells that have been primed for IL-12 production. IL-7, which has been used with dendritic cells to induce CTL responses (21) was not effective in our studies.
Restricted requirements for IL-12 in antiviral responses. The regulatory influence of IL-12 on cellular immune responses is most striking in animal models of bacterial and protozoal infection (reviewed in references 1 and 2). Surprisingly, less is known about the role of IL-12 in T cell-mediated resistance to viral infections. For instance, little is known about whether IL-12 plays a role in the development of antiviral CD8ϩ CTLs.
In two animal models of virus infection, lactate dehydrogenase elevating virus (34) and MCM virus infections (28) , either message for IL-12 or protein is detected in macrophages and splenic cells shortly after infection. However, the primary mode of virus clearance, at least in MCMV infection, appears to be via NK cells through secretion of IFN␥, rather than CD8ϩ T cells. This antiviral pathway is blocked with anti-IL-12 antibody or enhanced with administration of low dose IL-12 (28) . In contrast, CD8ϩ T cell expansion is unaffected by IL-12 neutralizing antibody. In other virus infections IL-12 is not readily detectable, e.g., LCMV infection, and viral clear-ance is primarily dependent on the activation of CD8ϩ CTLs. While low doses of IL-12 enhance splenic CD8ϩ T cell numbers in LCMV-infected mice and decrease viral replication, cytolytic activity is not increased (35). Furthermore, the administration of anti-IL-12 antibody has no demonstrable effect on late T cell responses (28) . Thus we would predict that the ability to rapidly induce significant IL-12 levels in vivo will determine whether NK cells are major contributors to antiviral defense.
In humans, there is evidence to suggest that IL-12 has a critical function in the progression of HIV infection (26) . PBMCs from patients infected with this virus are deficient in their production of IL-12, and have suboptimal Th1 immune responses (36). Addition of IL-12 to T cells in vitro, restores recall responses to antigens (19, 26) . It is presumed, but not established, that IL-12 deficiency also affects antiviral CD8ϩ T cell development and function.
In the case of influenza virus, significant levels of IL-12 were not produced by either macrophages or dendritic cells after infection in vitro. IL-12 is reportedly produced in the lungs of mice as early as day 3 after infection with influenza virus, but it is not known which cells synthesize the cytokine (37) . Neutralizing anti-IL-12 antibodies increase morbidity in virusinfected mice compared with uninjected animals, suggesting that the cytokine is essential for a potent antiviral immune response (28) . Influenza virus infection is known to elicit IFN␥ production in infected human PBMCs (38) . Perhaps CD40L-bearing helper T cells are major inducers of IL-12 production by dendritic cells in infected lungs. Whether IL-12 is a requisite in vivo for clearance of influenza virus in humans cannot be determined from these experiments. Optimal clearing of influenza virus after infection likely requires CD8ϩ CTL effector activity (39) .
Applications. IL-12 may be a useful immunomodulator when used in conjunction with dendritic cells, to enhance antigen-specific class I restricted CD8ϩ CTL responses in viral infections and tumors. Peptide pulsed dendritic cells induce protective immune responses and also cause tumor regression of established metastases (40) (41) (42) . The concomitant use of IL-12 may reduce the need for large numbers or doses of dendritic cells. Similarly, by using dendritic cells, it may be feasible to use very low doses of IL-12. Large doses of IL-12 have exhibited toxicities in both humans and in animals (43) . In HIV infection, PBMC from infected patients demonstrate impaired IL-12 production (36). Immunotherapy may be most effective in later stages of the disease when CD4ϩ T cell counts fall and CD8ϩ CTL function declines. Here, IL-12 could concomitantly enhance virus-specific CTL responses as well as CD4ϩ helper cell responses, the latter as previously described (26) .
